Thrombospondin 1 activates the macrophage Toll-like receptor 4 pathway

Cellular and Molecular Immunology

Volumn 10, Issue 6, 2013, Pages 506-512

  Li, Yanzhang ^a,b   Qi, Xinyu ^a   Tong, Xiaopeng ^a   Wang, Shuxia ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b HENAN UNIVERSITY   (China)

Author keywords

CD36; macrophage; thrombospondin 1; TLR4; TNF

Indexed keywords

CD36 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PEPTIDE DERIVATIVE; PROTEIN ANTIBODY; RECOMBINANT PROTEIN; THROMBOSPONDIN 1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

ANIMALS; ANTIGENS, CD36; BASE SEQUENCE; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROTEIN BINDING; SIGNAL TRANSDUCTION; THROMBOSPONDIN 1; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84888318384     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2013.32     Document Type: Article

References (39)

1. Lawler JW, Slayter HS, Coligan JE. Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J Biol Chem 1978; 253: 8609-8616. (Pubitemid 9082569)
2. Baenziger NL, Brodie GN, Majerus PW. A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci USA 1971; 68: 240-243.
3. Donoviel DB, Amacher SL, Judge KW, Bornstein P. Thrombospondin gene expressionis associated with mitogenesis in3T3 cells: induction by basic fibroblast growth factor. J Cell Physiol 1990; 145: 16-23.
4. Phelan MW, Forman LW, Perrine SP, Faller DV. Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells. J Lab Clin Med 1998; 132: 519-529. (Pubitemid 28564710)
5. Bornstein P. Thrombospondins as matricellular modulators of cell function. J Clin Invest 2001; 107: 929-934. (Pubitemid 32323400)
6. Hugo C, Pichler R, Meek R, Gordon K, Kyriakides T, Floege J et al. Thrombospondin1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF invivo. Kidney Int 1995; 48: 1846-1856.
7. Ramis JM, Franssen-van Hal NL, Kramer E, Llado I, Bouillaud F, Palou A et al. Carboxypeptidase E and thrombospondin-1 are differently expressed in subcutaneous and visceral fat of obese subjects. Cell Mol Life Sci 2002; 59: 1960-1971. (Pubitemid 36015868)
8. Murphy-Ullrich JE, Mosher DF. Interactions of thrombospondin with endothelial cells: receptor-mediated binding and degradation. J Cell Biol 1987; 105: 1603-1611.
9. Taraboletti G, Roberts DD, Liotta LA. Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. J Cell Biol 1987; 105: 2409-2415. (Pubitemid 18019089)
10. Mikhailenko I, Krylov D, Argraves KM, Roberts DD, Liau G, Strickland DK. Cellular internalization and degradation of thrombospondin-1 is mediated by the amino-terminal heparin binding domain (HBD). High affinity interaction of dimeric HBD with the low density lipoprotein receptor-related protein. J Biol Chem 1997; 272: 6784-6791. (Pubitemid 27118167)
11. Wang S, Herndon ME, Ranganathan S, Godyna S, Lawler J, Argraves WS et al. Internalization but not binding of thrombospondin-1 to low density lipoprotein receptor-related protein-1 requires heparan sulfate proteoglycans. J Cell Biochem 2004; 91: 766-776.
12. Frazier WA, Gao AG, Dimitry J, Chung J, Brown EJ, Lindberg FP et al. The thrombospondin receptor integrin-associated protein (CD47) functionally couples to heterotrimeric Gi. J Biol Chem 1999; 274: 8554-8560. (Pubitemid 29164646)
13. Lawler J, Weinstein R, Hynes RO. Cell attachment to thrombos-pondin: the role of ARG-GLY-ASP, calcium, and integrin receptors. J Cell Biol 1988; 107(6 Pt 1): 2351-2361. (Pubitemid 19015113)
14. Gao AG, Lindberg FP, Finn MB, Blystone SD, Brown EJ, Frazier WA. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem 1996; 271: 21-24. (Pubitemid 26026555)
15. Chandrasekaran L, He CZ, Al-Barazi H, Krutzsch HC, Iruela-Arispe ML, Roberts DD. Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1. Mol Biol Cell 2000; 11: 2885-2900. (Pubitemid 32107072)
16. Goicoechea S, Orr AW, Pallero MA, Eggleton P, Murphy-Ullrich JE. Thrombospondin mediates focal adhesion disassembly through interactions with cell surface calreticulin. J Biol Chem 2000; 275: 36358-36368.
17. Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 2000; 6: 41-48. (Pubitemid 30048524)
18. Voros G, Maquoi E, Demeulemeester D, Clerx N, Collen D, Lijnen HR. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology 2005; 146: 4545-4554. (Pubitemid 41324053)
19. Varma V, Yao-Borengasser A, Bodles AM, Rasouli N, Phanavanh B, Nolen GT et al. Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance. Diabetes 2008; 57: 432-439.
20. Li Y, Tong X, Rumala C, Clemons K, Wang S. Thrombospondin1 deficiency reduces obesity-associated inflammation and improves insulin sensitivity in a diet-induced obese mouse model. PLoS ONE 2011; 6: e26656.
21. Nguyen MT, Favelyukis S, Nguyen AK, Reichart D, Scott PA, Jenn A et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 2007; 282: 35279-35292. (Pubitemid 350232441)
22. Mwaikambo BR, Sennlaub F, Ong H, Chemtob S, Hardy P. Activation of CD36 inhibits and induces regression of inflammatory corneal neovascularization. Invest Ophthalmol Vis Sci 2006; 47: 4356-4364. (Pubitemid 46579359)
23. Mwaikambo BR, Yang C, Chemtob S, Hardy P. Hypoxia up-regulates CD36 expression and function via hypoxia-inducible factor-1-and phosphatidylinositol 3-kinase-dependent mechanisms. J Biol Chem 2009, 284: 26695-26707.
24. Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA. Altered 5-hydroxytryptamine signaling in patients with constipation-and diarrhea-predominant irritable bowel syndrome. Gastroenterology 2006; 130: 34-43. (Pubitemid 43049833)
25. Frolova EG, Pluskota E, Krukovets I, Burke T, Drumm C, Smith JD et al. Thrombospondin-4 regulates vascular inflammation and atherogenesis. Circ Res 2010; 107: 1313-1325.
26. Vogel CF, Garcia J, Wu D, Mitchell DC, Zhang Y, Kado NY et al. Activation of inflammatory responses in human U937 macrophages by particulate matter collected from dairy farms: aninvitro expression analysis of pro-inflammatory markers. Environ Health 2012; 11: 17.
27. Febbraio M, Hajjar DP, Silverstein RL. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 2001; 108: 785-791. (Pubitemid 32880285)
28. Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 2010; 11: 155-161.
29. Leung LL, Li WX, McGregor JL, Albrecht G, Howard RJ. CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction. J Biol Chem 1992, 267: 18244-18250.
30. Frieda S, Pearce A, Wu J, Silverstein RL. Recombinant GST/CD36 fusion proteins define a thrombospondin binding domain. Evidence for a single calcium-dependent binding site on CD36. J Biol Chem 1995; 270: 2981-2986.
31. Bauer EM, Qin Y, Miller TW, Bandle RW, Csanyi G, Pagano PJ et al. Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation. Cardiovasc Res 2010; 88: 471-481.
32. Choi KY, Kim DB, Kim MJ, Kwon BJ, Chang SY, Jang SW et al. Higher plasma thrombospondin-1 levels in patients with coronary artery disease and diabetes mellitus. Korean Circ J 2012; 42: 100-106.
33. Rallabhandi P, Bell J, Boukhvalova MS, Medvedev A, Lorenz E, Arditi M et al. Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J Immunol 2006; 177: 322-332. (Pubitemid 43939144)
34. Salajegheh M, Raju R, Schmidt J, Dalakas MC. Upregulation of thrombospondin-1 (TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositis. J Neuroimmunol 2007; 187: 166-174. (Pubitemid 47008931)
35. Lawler J, Sunday M, Thibert V, Duquette M, George EL, Rayburn H et al. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 1998; 101: 982-992. (Pubitemid 28125276)
36. Schultz-Cherry S, Murphy-Ullrich JE. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol 1993; 122: 923-932. (Pubitemid 23241101)
37. Young GD, Murphy-Ullrich JE. Molecular interactions that confer latency to transforming growth factor-beta. J Biol Chem 2004; 279: 38032-38039. (Pubitemid 39195519)
38. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO et al. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998; 93: 1159-1170. (Pubitemid 28307421)
39. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993; 90: 770-774. (Pubitemid 23028947) Diseases